Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cotinga Pharmaceuticals Inc COT


Primary Symbol: COTQF

Healthcare Biotechnology
Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.


GREY:COTQF - Post by User

Cotinga Pharmaceuticals Inc
Bullboard Posts
User Avatar Image
(0)
•••
Post by onemorespideron Feb 07, 2006 5:21pm
456 Views
Post# 10309944

Insider action

Insider actionA search of sedi (Jan 1/03 to Feb 6/06) shows nothing but the sale of option gained shares. However US SEC filings for Feb 6 & 7, 2006 show open market buys of 10,000 shares by the CFO and 20,000 shares by the CEO. https://www.insiderscoop.com/ViewFiling/ViewFiling.aspx?accessionNo=0001194068-06-000001 https://www.sec.gov/Archives/edgar/data/884713/000118850806000002/xslF345X02/primary_doc.xml I believe this is a positive signal that the bottom has been reached. Your friendly neighbourhood web spinner!
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities